| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2023―Nov―14 |
Coffee as a dietary strategy to prevent SARS-CoV-2 infection |
Chen-Shiou Wu, Yi-Chuan Li, Shin-Lei Peng, Chung-Yu Chen, Hsiao-Fan Chen, Po-Ren Hsueh, et al. (+6) Wei-Jan Wang, Yen-Yi Liu, Ciao-Ling Jiang, Wei-Chao Chang, Shao-Chun Wang, Mien-Chie Hung |
| 2 |
[GO] |
2023―Aug―31 |
Engineered clinical-grade mesenchymal stromal cells combating SARS-CoV-2 omicron variants by secreting effective neutralizing antibodies |
Yanning Wang, Tianyun Gao, WanTing Li, Chenxu Tai, Yuanyuan Xie, Dong Chen, et al. (+5) Shuo Liu, Feifei Huang, Wenqing Wang, Yuxin Chen, Bin Wang |
| 3 |
[GO] |
2023―Jun―28 |
Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2 |
Fang-Ju Cheng, Chien-Yi Ho, Tzong-Shiun Li, Yeh Chen, Yi-Lun Yeh, Ya-Ling Wei, et al. (+11) Thanh Kieu Huynh, Bo-Rong Chen, Hung-Yu Ko, Chen-Si Hsueh, Ming Tan, Yang-Chang Wu, Hui-Chi Huang, Chih-Hsin Tang, Chia-Hung Chen, Chih-Yen Tu, Wei-Chien Huang |
| 4 |
[GO] |
2022―Okt―01 |
Revisiting potential value of antitumor drugs in the treatment of COVID-19 |
Wenfang Zheng, Zekun Zeng, Shumei Lin, Peng Hou |
| 5 |
[GO] |
2022―Jun―11 |
Development of a novel human CD147 knock-in NSG mouse model to test SARS-CoV-2 viral infection |
Saiaditya Badeti, Qingkui Jiang, Alireza Naghizadeh, Hsiang-chi Tseng, Yuri Bushkin, Salvatore A. E. Marras, et al. (+12) Annuurun Nisa, Sanjay Tyagi, Fei Chen, Peter Romanienko, Ghassan Yehia, Deborah Evans, Moises Lopez-Gonzalez, David Alland, Riccardo Russo, William Gause, Lanbo Shi, Dongfang Liu |
| 6 |
[GO] |
2022―Mai―19 |
Ginkgolic acid and anacardic acid are reversible inhibitors of SARS-CoV-2 3-chymotrypsin-like protease |
Dongsheng Li, Gangan Yan, Wenwen Zhou, Shuyi Si, Xiaoping Liu, Jing Zhang, et al. (+2) Yan Li, Yunyu Chen |
| 7 |
[GO] |
2022―Mai―17 |
Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants |
Lili Li, Meiling Gao, Peng Jiao, Shulong Zu, Yong-qiang Deng, Dingyi Wan, et al. (+10) Yang Cao, Jing Duan, Saba R Aliyari, Jie Li, Yueyue Shi, Zihe Rao, Cheng-feng Qin, Yu Guo, Genhong Cheng, Heng Yang |
| 8 |
[GO] |
2022―Mrz―22 |
SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1 |
Sin-Yee Fung, Kam-Leung Siu, Huayue Lin, Ching-Ping Chan, Man Lung Yeung, Dong-Yan Jin |
| 9 |
[GO] |
2022―Mrz―20 |
Diabetes as a potential compounding factor in COVID-19-mediated male subfertility |
Qingkui Jiang, Thomas Linn, Karl Drlica, Lanbo Shi |
| 10 |
[GO] |
2022―Feb―09 |
Pseudomonas aeruginosa modulates alginate biosynthesis and type VI secretion system in two critically ill COVID-19 patients |
Jiuxin Qu, Zhao Cai, Xiangke Duan, Han Zhang, Hang Cheng, Shuhong Han, et al. (+8) Kaiwei Yu, Zhaofang Jiang, Yingdan Zhang, Yang Liu, Fang Bai, Yingxia Liu, Lei Liu, Liang Yang |
| 11 |
[GO] |
2022―Feb―09 |
Transcriptional landscape of circulating platelets from patients with COVID-19 reveals key subnetworks and regulators underlying SARS-CoV-2 infection: implications for immunothrombosis |
Weiping Ji, Lu Chen, Wei Yang, Ke Li, Jingting Zhao, Congcong Yan, et al. (+4) Cancan You, Minghua Jiang, Meng Zhou, Xian Shen |
| 12 |
[GO] |
2021―Dez―18 |
SARS-CoV-2 and COVID-19: revisiting the most important research questions |
Kit-San Yuen, Zi-Wei Ye, Sin-Yee Fung, Pak-Hin Hinson Cheung, Chi-Ping Chan, Dong-Yan Jin |
| 13 |
[GO] |
2021―Dez―08 |
Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2 |
Huibi Cao, Juntao Mai, Zhichang Zhou, Zhijie Li, Rongqi Duan, Jacqueline Watt, et al. (+14) Ziyan Chen, Ranmal Avinash Bandara, Ming Li, Sang Kyun Ahn, Betty Poon, Natasha Christie-Holmes, Scott D. Gray-Owen, Arinjay Banerjee, Karen Mossman, Rob Kozak, Samira Mubareka, James M. Rini, Jim Hu, Jun Liu |
| 14 |
[GO] |
2021―Dez―05 |
Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors |
Gangan Yan, Dongsheng Li, Yuan Lin, Zhenghao Fu, Haiyan Qi, Xiaoping Liu, et al. (+3) Jing Zhang, Shuyi Si, Yunyu Chen |
| 15 |
[GO] |
2021―Nov―21 |
Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients |
Cong Zeng, John P. Evans, Sarah Reisinger, Jennifer Woyach, Christina Liscynesky, Zeinab El Boghdadly, et al. (+8) Mark P. Rubinstein, Karthik Chakravarthy, Linda Saif, Eugene M. Oltz, Richard J. Gumina, Peter G. Shields, Zihai Li, Shan-Lu Liu |
| 16 |
[GO] |
2021―Sep―08 |
Inferring SARS-CoV-2 functional genomics from viral transcriptome with identification of potential antiviral drugs and therapeutic targets |
Xu Pan, Xin Li, Shangwei Ning, Hui Zhi |
| 17 |
[GO] |
2021―Aug―30 |
Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor |
Jinbiao Liu, Brittany H. Bodnar, Fengzhen Meng, Adil I. Khan, Xu Wang, Sami Saribas, et al. (+11) Tao Wang, Saroj Chandra Lohani, Peng Wang, Zhengyu Wei, Jinjun Luo, Lina Zhou, Jianguo Wu, Guangxiang Luo, Qingsheng Li, Wenhui Hu, Wenzhe Ho |
| 18 |
[GO] |
2021―Aug―22 |
An update on novel approaches for diagnosis and treatment of SARS-CoV-2 infection |
Azadeh Safarchi, Shadma Fatima, Zahra Ayati, Fatemeh Vafaee |
| 19 |
[GO] |
2021―Jul―22 |
Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV-2 replication |
Yiling Jiang, Kuijie Tong, Roubin Yao, Yuanze Zhou, Hanwen Lin, Liubing Du, et al. (+7) Yunyun Jin, Liu Cao, Jingquan Tan, Xing-Ding Zhang, Deyin Guo, Ji-An Pan, Xiaoxue Peng |
| 20 |
[GO] |
2021―Jul―19 |
Differing susceptibility of C57BL/6J and DBA/2J mice-parents of the murine BXD family, to severe acute respiratory syndrome coronavirus infection |
Kui Li, Yang Shen, Mark A. Miller, Jennifer Stabenow, Robert W. Williams, Lu Lu |
| 21 |
[GO] |
2021―Jul―19 |
SARS-CoV-2: from its discovery to genome structure, transcription, and replication |
Ayslan Castro Brant, Wei Tian, Vladimir Majerciak, Wei Yang, Zhi-Ming Zheng |
| 22 |
[GO] |
2021―Jul―08 |
A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses |
Yanxing Cai, Wei Xu, Jiayi Tang, Najing Cao, Qiaoshuai Lan, Lu Lu, Shibo Jiang |
| 23 |
[GO] |
2021―Jun―23 |
Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion |
Xuening Wang, Chih-Hsiung Chen, Saiaditya Badeti, Jong Hyun Cho, Alireza Naghizadeh, Ziren Wang, Dongfang Liu |
| 24 |
[GO] |
2021―Jun―13 |
Drosophila, a powerful model to study virus-host interactions and pathogenicity in the fight against SARS-CoV-2 |
Joyce van de Leemput, Zhe Han |
| 25 |
[GO] |
2021―Mrz―25 |
Functional analysis of SARS-CoV-2 proteins in Drosophila identifies Orf6-induced pathogenic effects with Selinexor as an effective treatment |
Jun-yi Zhu, Jin-Gu Lee, Joyce van de Leemput, Hangnoh Lee, Zhe Han |
| 26 |
[GO] |
2021―Mrz―25 |
Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor |
Jin-Gu Lee, Weiliang Huang, Hangnoh Lee, Joyce van de Leemput, Maureen A. Kane, Zhe Han |
| 27 |
[GO] |
2021―Feb―28 |
Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases |
Zinuo Chen, Qinghua Cui, Laura Cooper, Pin Zhang, Hyun Lee, Zhaoyu Chen, et al. (+4) Yanyan Wang, Xiaoyun Liu, Lijun Rong, Ruikun Du |
| 28 |
[GO] |
2020―Dez―30 |
ACE2: the molecular doorway to SARS-CoV-2 |
Miriam Marlene Medina-Enríquez, Sandra Lopez-León, José Alberto Carlos-Escalante, Zuleika Aponte-Torres, Angelica Cuapio, Talia Wegman-Ostrosky |
| 29 |
[GO] |
2020―Mrz―16 |
SARS-CoV-2 and COVID-19: The most important research questions |
Kit-San Yuen, Zi -Wei Ye, Sin-Yee Fung, Chi-Ping Chan, Dong-Yan Jin |
|
